[1]Frontoni S, Di Bartolo P, Avogaro A, et al. Glucose variability: An emerging target for the treatment of diabetes mellitus[J]. Diabetes Res Clin Pract,2013,102(2):86-95.
[2]Bao YQ, Zhou M, Zhou J, et al. Relationship between serum osteocalcin and glycaemic variability in Type 2 diabetes[J]. Clin Exp Pharmacol Physiol,2011,38(1):50-54.
[3]Gylfe E, Gilon P. Glucose regulation of glucagon secretion[J]. Diabetes Res Clin Pract,2014,103(1):1-10.
[4]Talchai C, Xuan S, Lin HV, et al. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure[J]. Cell,2012,150(6):1223-1234.
[5]Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains[J]. Endocr Rev,2007,28(1):84-116.
[6]Soliman A, Desanctis V, Yassin M, et al. Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups[J]. Indian J Endocrinol Metab,2014,18(3):274-282.
[7]Yoon U, Kwok LL, Magkidis A. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials[J]. Metabolism,2013,62(2):303-314.
[8]Schiaffini R, Brufani C, Russo B, et al. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system[J]. Eur J Endocrinol,2010,162(4):705-710. .
[9]曹怡,邱春娟,焦秀敏,等. 动态血糖监测在单纯性肥胖患者中的应用[J]. 中国卫生检验杂志,2015,25(18):3119-3122.
[10]Yang L, Colditz GA. Prevalence of Overweight and Obesity in the United States, 2007-2012[J]. JAMA Intern Med,2015,175(8):1412-1413.
[11]梁菁菁,蒋戚. 11β-羟基类固醇脱氢酶抑制剂的临床应用[J]. 东南国防医药,2012,14(2):149-151.
[12]Ma CM, Yin FZ, Wang R, et al. Glycemic variability in abdominally obese men with normal glucose tolerance as assessed by continuous glucose monitoring system[J]. Obesity (Silver Spring),2011,19(8):1616-1622.
[13]彭朝胜,曹悦鞍,刘淑云,等. 肥胖患者血糖波动的特点[J]. 现代医学,2011(4):424-426.
[14]Morandi A, Maschio M, Marigliano M, et al. Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study[J]. Pediatr Obes,2014,9(1):17-25.
[15]El AA, Soliman A, Al-Ali M, et al. Continuous glucose monitoring, oral glucose tolerance, and insulin-glucose parameters in adolescents with simple obesity[J]. Georgian Med News,2012(210):47-53.
[16]华飞,吕欣,项守奎,等.多囊卵巢综合征患者血清骨钙素水平的变化[J].医学研究生学报,2016,29(6):625-628.
[17]陶敏芳,朱洁萍,周健,等. 糖耐量正常的多囊卵巢综合征者胰岛素分泌功能及血糖波动变化的研究[J]. 中华医学杂志,2009,89(10):659-663.
[18]Buckley BS, Harreiter J, Damm P, et al. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review[J]. Diabet Med,2012,29(7):844-854.
[19]中国2型糖尿病防治指南(2013年版)[J]. 中国糖尿病杂志,2014(8):2-42.
[20]Shin NR, Yoon SY, Cho GJ, et al. A Korean multicenter study of prenatal risk factors for overt diabetes during the postpartum period after gestational diabetes mellitus[J]. Int J Gynaecol Obstet,2016,132(3):342-346.
[21]Bartakova V, Maluskova D, Muzik J, et al. Possibility to predict early postpartum glucose abnormality following gestational diabetes mellitus based on the results of routine mid-gestational screening[J]. Biochem Med (Zagreb),2015,25(3):460-468.
[22]Wang YM, Zhao LH, Su JB, et al. Glycemic variability in normal glucose tolerance women with the previous gestational diabetes mellitus[J]. Diabetol Metab Syndr,2015,7:82. doi: 10.1186/s13098-015-0077-5.
[23]Scott RA, Langenberg C, Sharp SJ, et al. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study[J]. Diabetologia,2013,56(1): 60-69.
[24]Madhu SV, Muduli SK, Avasthi R. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients[J]. Diabetes Technol Ther,2013,15(6):461-465.
[25]Priya M, Anjana RM, Chiwanga FS, et al. 1-hour venous plasma glucose and incident prediabetes and diabetes in Asian indians[J]. Diabetes Technol Ther,2013,15(6):497-502.
[26]Su JB, Chen T, Xu F, et al. Glycemic variability in normal glucose regulation subjects with elevated 1-h postload plasma glucose levels[J]. Endocrine,2014,46(2):241-248.
[27]Fiorentino TV, Marini MA, Andreozzi F, et al. One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose[J]. J Clin Endocrinol Metab,2015,100(10):3744-3751.
[28]Shi XL, Ren YZ, Wu J. Intermittent high glucose enhances apoptosis in INS-1 cells[J]. Exp Diabetes Res,2011,2011:754673. doi: 10.1155/2011/754673.
[29]张颖,李冬梅,李倩,等.甘精胰岛素治疗对2型糖尿病患者丙二醛及C反应蛋白水平的影响[J].医学研究生学报,2011,24(1):49-54.
[1]杨 琛,殷思雨,张春妮.糖化低密度脂蛋白与糖尿病患者动脉粥样硬化的相关研究[J].医学研究与战创伤救治(原医学研究生学报),2013,15(03):269.[doi:10.3969/j.issn.1672-271X.2013.03.020]
[2]刘春燕,张 珍,易秋艳,等.银杏叶提取物对db/db糖尿病小鼠胰岛功能的影响[J].医学研究与战创伤救治(原医学研究生学报),2013,15(04):325.[doi:10.3969/j.issn.1672-271X.2013.04.002]
LIU Chun-yan,ZHANG Zhen,YI Qiu-yan,et al.The effects of EGb761 on islet function in db/db mice[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(06):325.[doi:10.3969/j.issn.1672-271X.2013.04.002]
[3]吴勤研,王 楠,倪江洪.我院2010-2012年注射用胰岛素使用情况分析[J].医学研究与战创伤救治(原医学研究生学报),2013,15(05):480.[doi:10.3969/j.issn.1672-271X.2013.05.016]
WU Qin-yan,WANG Nan,NI Jiang-hong.Analysis of the use of insulin in our hospital during period of 2010-2012[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(06):480.[doi:10.3969/j.issn.1672-271X.2013.05.016]
[4]刘 婷,丁 颖,朱 婷,等.92例糖尿病患者白内障超声乳化围手术期安全性的临床分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(06):542.
[5]余 涛,李秀增,戴 明,等.二甲双胍联合米氮平治疗2型糖尿病合并抑郁症30例[J].医学研究与战创伤救治(原医学研究生学报),2012,14(01):60.
[6]赖晓荣,朱欣娟,黄银霞.胰岛素泵在骨折合并糖尿病患者围手术期的应用及护理[J].医学研究与战创伤救治(原医学研究生学报),2012,14(01):76.
[7]梁菁菁,蒋 戚.11β-羟基类固醇脱氢酶抑制剂的临床应用[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):149.
[8]梁菁菁,蒋 戚,邹大进.羟氯喹治疗2型糖尿病[J].医学研究与战创伤救治(原医学研究生学报),2012,14(03):267.
[9]杨燕玲,吕飞娟,江 辉,等.电话随访对提高2型糖尿病胰岛素治疗依从性的影响[J].医学研究与战创伤救治(原医学研究生学报),2011,13(01):63.
[10]张 慧,朱孝春,王 莉,等.法舒地尔治疗2型糖尿病伴白蛋白尿的临床观察[J].医学研究与战创伤救治(原医学研究生学报),2011,13(01):66.